Medigen Biotechnology Corp. (TPEX:3176)
Taiwan
· Delayed Price · Currency is TWD 30.40
-0.10 (-0.33%)
Aug 15, 2025, 2:31 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| Generic Drug, Aesthetic Medicine Product and Dietary Supplement | 695.08M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Generic Drug, Aesthetic Medicine Product and Dietary Supplement Growth | -1.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Drug and Vaccine Research and Development | 605.64M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Drug and Vaccine Research and Development Growth | 55.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nucleic Acid | 62.53M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nucleic Acid Growth | 5.91% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cytotherapy | 9.45M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cytotherapy Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| Taiwan | 1.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Taiwan Growth | 17.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Countries | 23.99M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Countries Growth | 383.88% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 4.44M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -29.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|